Topic summary

Official shortage notices and what they authorise

Access › Shortages compounding formulary shortage

This is a generated summary. It shows the 9 most-liked posts from a topic of 120, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

a.villalobosTL27 Apr 2026#1

Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that.

Trying to work out what would count as evidence on official shortage notices, before collecting any. This is the part I usually skip and it is the part that makes the rest useful.

If two explanations predict the same observation, observing it does not help. So: what observation would separate them?

31 likes 4mo

peak_purityTL3Analytical chemist9 Apr 2026#2

Right — I had this wrong and I am glad to have read it before it mattered.

32 likes 4mo

g.ibarraTL228 Apr 2026#24

Post #20 describes the usual case. This is about the unusual one.

Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.

Correct me on the arithmetic if it is wrong; I would rather know.

30 likes 3mo

il.dumitruTL21 May 2026#29

s.ivaturi, post #14: This follows post #13 rather than contradicting it. Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite. If that is already documented somewhere, ignore me and link it. Go to post

Taking post #27 at face value and following it one step further.

International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is prudent if you can.

Not a strong opinion, just a consistent one.

31 likes in reply to #14 3mo

DSakamotoTL3Regular6 May 2026#36

Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.

Noting that I have skin in this question and have tried to discount for it.

28 likes 3mo

j.teixeiraTL218 May 2026#56

Taking post #54 at face value and following it one step further.

I have no financial interest in anything named in this thread and I want to say so before I comment on official shortage notices, because it is the sort of subject where it matters.

31 likes 2mo

k.asanteTL221 May 2026#61

g.haaland, post #30: Post #28 and I disagree about the size of the effect, not about the direction. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are different decisions. That is the shape of it. The detail is where I would expect to be… Go to post

Understood, and I withdraw the assumption I opened with.

32 likes in reply to #30 2mo

b.friskTL24 Jun 2026#86

e.silva, post #42: Worth separating two things that post #38 runs together. The most useful contribution is a link to the current official notice rather than an account of one pharmacy. Two sources, same conclusion, and I could not rule out that one copied the other. Go to post

Where I part company with post #82, and it is a narrow parting.

Official shortage notices came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.

32 likes in reply to #42 2mo

e.tammTL210 Jun 2026#98

h.fonseca, post #45: Taking post #44 at face value and following it one step further. Official shortage notices: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this. Go to post

The most useful contribution is a link to the current official notice rather than an account of one pharmacy.

It is worth stating the boring hypothesis before the interesting one.

30 likes in reply to #45 2mo

Read the full topic (120 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Managing an unplanned gap in supply Access › Shortages shortage formulary FDA compounding Managing an unplanned gap in supply — setting out what I have, and where I think it stops being reliable. A narrow question about managing an unplanned gap, deliberately narrow, because the broad version has…	+105	110	5.1k	3mo
How shortages have affected compounding permissions — does this still hold? Access › Shortages compounding shortage formulary FDA Solved How shortages have affected compounding permissions — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about shortages directly, because I…	+27	31	21k	17h
Coming back to: Official shortage notices and what they authorise Access › Shortages FDA compounding shortage formulary Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. Official shortage notices — I have the observation and I do not trust my…	+85	92	5.5k	11mo
Managing an unplanned gap in supply — what changed since Access › Shortages compounding FDA formulary On the subject in the title: Managing an unplanned gap in supply — what changed since Working notes rather than a conclusion. What changes if the standard account of Managing an unplanned gap is wrong? I ask…	+114	124	54k	8mo
How shortages have affected compounding permissions Access › Shortages shortage compounding FDA formulary How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to know what people here actually do about shortages,…	+61	71	3.6k	2d

Related topics — sharing the tags compounding, formulary, shortage

Topic	Participants	Replies	Views	Activity
Prior authorisation: what the criteria usually require Access › Insurance & coverage prior authorisation formulary appeals insurance Solved On the subject in the title: Prior authorisation: what the criteria usually require Working notes rather than a conclusion. I would like to know what people here actually do about prior authorisation, as…	+9	13	3.2k	17mo
List price versus negotiated price versus what you pay Access › Pricing formulary data table compounding Under review On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. List price versus negotiated price — I have the observation and I do not trust my…	+99	115	11k	3mo
External review after an internal denial Access › Insurance & coverage appeals prior authorisation insurance formulary Solved External review after an internal denial Writing it up because I had to work it out twice and would rather nobody else did. Proposing that external review deserves a maintained page rather than a recurring…		2	18k	1mo
Why a compound being unapproved is not the same as being illegal to possess Sourcing › Regulatory FDA MHRA research use only EMA Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about compound…	+72	78	23k	3mo
Peer-to-peer review: what actually happens on the call — one year on Access › Insurance & coverage appeals formulary insurance Peer-to-peer review: what actually happens on the call — one year on — setting out what I have, and where I think it stops being reliable. The question about Peer-to-peer review that I actually want answered…	+2	6	41k	5mo